Related Experiment Videos
[Influenza A pneumonia]
R P Veenstra1, C C Boelen, J G Zijlstra
1Afd. Interne Geneeskunde, Academisch Ziekenhuis, Groningen.
Abstract:
The majority of influenza cases are not associated with complications. Secondary bacterial pneumonia, commonly caused by Streptococcus pneumoniae or Staphylococcus aureus, is well known to most clinicians. Primary influenza viral pneumonia, characterized by rapidly progressive hypoxia and respiratory insufficiency together with non-consolidating pulmonary infiltrates, has a high mortality rate. In 3 patients, a man aged 74 years, and two neonates aged 11 months and 4 weeks respectively, primary influenza A pneumonia was diagnosed. In the latter two patients the virus was cultivated from sputum. Despite intensive supporting and drug treatment, the first and the last patients died. In view of evolving therapeutic possibilities, notably regarding neuraminidase inhibitors, it is important that clinicians recognize this complication of influenza at an early stage.
Insights
Primary influenza A pneumonia is a rare but severe complication. Early recognition is crucial for timely treatment with antiviral medications like neuraminidase inhibitors, improving patient outcomes.
Area of Science:
- Infectious Diseases
- Pulmonology
- Virology
Background:
- Influenza typically causes mild illness, but severe complications like pneumonia can occur.
- Secondary bacterial pneumonia is a known complication, but primary viral pneumonia is less common.
- Primary influenza viral pneumonia presents with severe respiratory distress and has a high mortality rate.
Observation:
- Three cases of primary influenza A pneumonia were diagnosed in a 74-year-old man and two neonates (11 months and 4 weeks old).
- Influenza A virus was isolated from sputum in the two infant patients.
- Two of the three patients, including the elderly man and the youngest infant, did not survive despite intensive care.
Findings:
- Primary influenza A pneumonia is a distinct and severe clinical entity.
- This complication affects both elderly and very young patients.
- The condition is associated with a high fatality rate.
Implications:
- Early clinical recognition of primary influenza pneumonia is vital for prompt intervention.
- Antiviral therapies, such as neuraminidase inhibitors, offer potential treatment avenues.
- Increased awareness among clinicians can improve management and outcomes for this severe influenza complication.